Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients

Overview of attention for article published in BMC Cancer, August 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 21 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,548 followers.

@Whatapityonyou @Apayauq1 The vaccine is available in the US under trial and in other countries as well. https://t.co/QvYYbc2dJp. Also, they still don't have reliable biomarkers for which patients with NSCLC will benefit from this vaccine, which is why i

01 May 2021

Reply Repost Favourite

PubMed: https://t.co/hcZuMF9cmX Identifying predictive biomarkers of CIMAvaxEGF success in non-small cell lung cancer patients. Identifying predictive biomarkers of CIMAvaxEGF success in non-small cell lung cancer patients. BMC Cancer. 2020 Aug 17;20(1):

19 Aug 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.